SV Health Investors has raised $400 million for its SV Life Sciences Fund VI. The Boston-headquartered firm began fundraising in 2015 with a $400 million target.
Its previous fund raised $524 million in 2010.
Investors that committed to SV Life Sciences Fund VI include the University of Houston System.
The fund will target early-stage and growth equity opportunities in healthcare and digital health sectors in North America and Europe.